Clinical trials
Completed Insulin Resistance trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 6 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Guadalajara | 14 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 5 |
| Coordinación de Investigación en Salud, Mexico | 4 |
| Eli Lilly and Company | 3 |
| Universidad de Guanajuato | 3 |
| AstraZeneca | 1 |
| Centro Universitario de Ciencias de la Salud, Mexico | 1 |
| Hospital Central "Dr. Ignacio Morones Prieto" | 1 |
| Hospital Infantil de Mexico Federico Gomez | 1 |
| Hospital Regional de Alta Especialidad del Bajio | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 43 |
| Metabolic Syndrome | 11 |
| Diabetes Mellitus, Type 2 | 9 |
| Obesity | 8 |
| Diabetes Mellitus | 7 |
| Glucose Intolerance | 4 |
| Obesity, Abdominal | 3 |
| Prediabetic State | 3 |
| Overweight | 2 |
| Pediatric Obesity | 2 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.